Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China · Delayed Price · Currency is CNY 12.03
-0.05 (-0.41%)
Jul 30, 2026, 3:04 PM CST
SHE:300452 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 956.32 | 942.8 | 882.57 | 839.26 | 704.53 | 616.71 |
Revenue Growth | 7.12% | 6.82% | 5.16% | 19.12% | 14.24% | 16.10% |
Gross Profit Gross Profit Growth | 303.04 | 298.86 | 273.23 | 265.33 | 209.24 | 177.78 |
Operating Income Operating Income Growth | 194.42 | 191.22 | 170.43 | 161.34 | 121.01 | 93.08 |
Net Income Net Income Growth | 176.44 | 176.55 | 119.42 | 161.54 | 130.71 | 89.25 |
Earnings Per Share EPS Growth | 0.73 | 0.73 | 0.51 | 0.67 | 0.56 | 0.38 |
EPS Growth | 48.10% | 43.14% | -23.88% | 19.64% | 47.37% | -6.79% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Medicine Manufacturing Medicine Manufacturing Growth | 942.4 | 882.29 | 838.96 | 704.18 | 616.38 |
Site Lease Income Site Lease Income Growth | 0.4 | 0.29 | 0.3 | 0.34 | 0.33 |
Total Total Growth | 942.8 | 882.57 | 839.26 | 704.53 | 616.71 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 827.94 | 820.97 | 708.32 | 685.73 | 364.68 | 329.14 |
Total Debt Total Debt Growth | 331.42 | 314.71 | 304.98 | 297.6 | 39.84 | 31.04 |
Net Cash (Debt) Net Cash Growth | 496.52 | 506.26 | 403.35 | 388.13 | 324.84 | 298.11 |
Net Cash Growth | 30.80% | 25.51% | 3.92% | 19.48% | 8.97% | 14.45% |
Net Cash Per Share Net Cash Per Share Growth | 2.05 | 2.09 | 1.72 | 1.61 | 1.39 | 1.27 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 212.87 | 191.99 | 118.33 | 132.3 | 132.82 | 103.82 |
Capital Expenditures CapEx Growth | -43.61 | -40.73 | -27.94 | -54.92 | -67.31 | -31.47 |
Free Cash Flow Free Cash Flow Growth | 169.27 | 151.26 | 90.39 | 77.38 | 65.5 | 72.35 |
Free Cash Flow Growth | 87.63% | 67.34% | 16.82% | 18.13% | -9.46% | 12.71% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.69% | 31.70% | 30.96% | 31.61% | 29.70% | 28.83% |
Operating Margin | 20.33% | 20.28% | 19.31% | 19.22% | 17.18% | 15.09% |
Pretax Margin | 20.91% | 21.07% | 16.13% | 22.14% | 19.36% | 15.68% |
Profit Margin | 18.45% | 18.73% | 13.53% | 19.25% | 18.55% | 14.47% |
FCF Margin | 17.70% | 16.04% | 10.24% | 9.22% | 9.30% | 11.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.300 | 0.300 | 0.250 | 0.250 | 0.231 |
Dividend Per Share Growth | 0% | 0% | 20.00% | 0% | 8.32% | 20.02% |
Dividend Yield | 2.52% | 2.30% | 2.60% | 1.88% | 1.55% | 1.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.55 | 17.63 | 23.59 | 20.48 | 31.15 | 43.88 |
Forward PE | 14.73 | 15.93 | 14.16 | 19.57 | 62.00 | 62.00 |
P/FCF Ratio | 16.60 | 20.58 | 31.17 | 42.76 | 62.16 | 54.13 |
PS Ratio | 2.94 | 3.30 | 3.19 | 3.94 | 5.78 | 6.35 |